Skip to content

Avanos Medical AVNS Inventory write-downs

Inventory write-downs at other companies

Novanta logo
NovantaNOVT
$710K-6.2%
Globus Medical logo
Globus MedicalGMED
$4.96M-16.8%
Charles River Laboratories logo
Charles River LaboratoriesCRL
$1.49M-78.0%

Other financials

Income statement

See full
Revenue$182.2M+8.8%
Gross profit$94.2M+4.9%
Operating income$8.9M-13.6%
Net income$5.1M-22.7%
EPS (diluted)$0.11-21.4%

Balance sheet

See full
Cash & equivalents$65.6M-32.4%
Total debt$138.4M-1.8%
Total equity$782.1M-6.8%
Total assets$1.1B-5.2%

Cash flow

See full
Operating cash flow-$12.3M-148%
CapEx$4.3M-35.8%
Free cash flow-$16.6M-187%

Valuation

See full
Market cap$1.17B+108%
Enterprise value$1.24B+105%
P/S1.6×+0.8×

Profitability

See full
Gross margin50%-4.6pp
Operating margin-9.1%-4.2pp
Net margin-10.4%-4.7pp
FCF margin1.6%-14.9pp

Returns & leverage

See full
Return on equity-9.2%-3.9pp
Debt / equity0.2×0.0×
Current ratio2.5×-0.1×

Where this comes from

Reported directly by Avanos Medical in its filing.

Tagged under the XBRL concept us-gaap:InventoryWriteDown.

The official record: Avanos Medical’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Avanos Medical's inventory write-downs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Avanos Medical's inventory write-downs?
Avanos Medical (AVNS) reported inventory write-downs of $3.3M in Q1 2026.
How has Avanos Medical's inventory write-downs changed year-over-year?
Avanos Medical's inventory write-downs increased by 94.1% year-over-year, from $1.7M to $3.3M.
What is the long-term trend for Avanos Medical's inventory write-downs?
Over 3 years (2022 to 2025), Avanos Medical's inventory write-downs has grown at a 3.0% compound annual growth rate (CAGR), from $8.6M to $9.4M.
What does inventory write-downs mean?
The expense recognized when the carrying value of inventory exceeds its net realizable value due to obsolescence, damage, or market price declines. High levels of write-downs may indicate poor inventory management or weakening demand for specific product lines.